Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/13/2003WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES
03/13/2003WO2002030465A3 Compositions that inhibit proliferation of cancer cells
03/13/2003WO2002029022A3 Chlorophyllases
03/13/2003WO2002029019A3 2.5-diketo-d-gluconic acid reductases and methods of use
03/13/2003WO2002026984A3 Potassium channel interactors and uses therefor
03/13/2003WO2002026983A3 56115, a novel human twik potassium channel and uses therefor
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2002026821A3 25658, a novel human calcium channel subunit and uses thereof
03/13/2003WO2002026802A3 M32404, a novel human trypsin and uses thereof
03/13/2003WO2002026801A3 Secreted proteins and their uses
03/13/2003WO2002024946A3 Quadruplex dna and duplex probe systems
03/13/2003WO2002024925A3 69109, a novel human tyrosine phosphatase and uses therefor
03/13/2003WO2002024920A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002024233A3 Control of nk cell function and survival by modulation of ship activity
03/13/2003WO2002022838A3 Transgenic poa grasses
03/13/2003WO2002022799A3 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof
03/13/2003WO2002022662A3 Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
03/13/2003WO2002022661A3 NOVEL PDEs AND USES THEREOF
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002020837A3 Method of nucleic acid typing or sequencing
03/13/2003WO2002020759A3 A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
03/13/2003WO2002020757A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002020749A3 Chimeric reporter system for cell surface receptor-ligand binding
03/13/2003WO2002020056A3 Methods and compositions for producing a neurosalutary effect in a subject
03/13/2003WO2002018552A3 Regulation of human aminotransferase-like enzyme
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002016655A3 Stress-regulated genes of plants, transgenic plants containing same, and methods of use
03/13/2003WO2002016416A3 Diagnosis and treatment of cardiovascular conditions
03/13/2003WO2002014497A3 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use
03/13/2003WO2002014487A3 Adeno-associated virus-mediated delivery of angiogenic factors
03/13/2003WO2002014471A3 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
03/13/2003WO2002013799A3 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof
03/13/2003WO2002012525A3 Helper functions for recombinant vector production
03/13/2003WO2002012280A3 Compositions and methods for the therapy and diagnosis of colon cancer
03/13/2003WO2002012272A8 Therapeutic anti-melanoma compounds
03/13/2003WO2002012271A3 Treatment of microbial infections with bacterial proteins and peptides
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2002008432A3 Composition and method for increased meiotic recombination in plants
03/13/2003WO2002008410A3 Nucleic acids compositions conferring dwarfing phenotype
03/13/2003WO2002008409A3 Methods for the replacement, translocation and stacking of dna in eukaryotic genomes
03/13/2003WO2002008401A3 Elongase genes and uses thereof
03/13/2003WO2002008391A3 Glycerol-3-phosphate/dihydroxyacetone phosphate dual substrate acyltransferases
03/13/2003WO2002008284A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002008278A3 Compositions and methods relating to lung specific genes
03/13/2003WO2002006485A3 47885, a novel human ubiquitin-activating enzyme and uses therefor
03/13/2003WO2002006340A3 Tetraspan protein and uses thereof
03/13/2003WO2002002639A3 Human ion channels
03/13/2003WO2002002635A3 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002000913A3 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
03/13/2003WO2002000690A3 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
03/13/2003WO2002000242A8 Human papilloma virus treatment
03/13/2003WO2001096598A3 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
03/13/2003WO2001096376A3 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
03/13/2003WO2001094625A3 Capture moieties for nucleic acids and uses thereof
03/13/2003WO2001090187A3 G-protein coupled olfactory receptors
03/13/2003WO2001090146A3 57256 and 58289, human transporters and uses thereof
03/13/2003WO2001088103A3 Compositions and methods for tissue dedifferentiation and regeneration
03/13/2003WO2001085946A3 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
03/13/2003WO2001083804A3 A method for improving recombinant protein stability and solubility
03/13/2003WO2001083797A3 Polynucleotides for use in recombinant adeno-associated virus virion production
03/13/2003WO2001081578A3 Novel proteins and nucleic acids encoding same
03/13/2003WO2001081375A3 Dna & protein binding miniature proteins
03/13/2003WO2001073074A3 18806, a novel trypsin serine protease-like molecule and uses thereof
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003WO2001060413A3 Recombinant vector expressing a beta2-adrenergic receptor and use in treating airway and vascular diseases
03/13/2003WO2001023410A3 Drug target isogenes: polymorphisms in the interleukin 13 gene
03/13/2003US20030051276 Interspecific Dianthus plant
03/13/2003US20030051275 Monocotyledonous plant cell or seed for use in generation of heterologous polypeptides
03/13/2003US20030051274 Process for producing female-sterile plants
03/13/2003US20030051273 Salicylic acid biosynthetic genes and uses thereof
03/13/2003US20030051272 Transgenic monocot for use in animal feeds and as human nutrients
03/13/2003US20030051271 DNA sequences for an amino acid transporter plasmids, bacteria, yeasts and plants containing a transporter and their use
03/13/2003US20030051270 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
03/13/2003US20030051268 CYT28 serpentine receptor disruptions, compositions and methods relating thereto
03/13/2003US20030051267 Targeted disruption of kinase suppressor of RAS
03/13/2003US20030051265 Efficient nuclear transfer with primordial gametes
03/13/2003US20030051264 Genetically modified cows having reduced susceptibility to mad cow disease
03/13/2003US20030051263 Genetic inhibition by double-stranded RNA
03/13/2003US20030051262 Generation of animal model for use in diagnosing and treating nervous system disorders; obtain animal, incubate with peptide, monitor brain activity, detect cellular degeneration, evaluate for brain disorder
03/13/2003US20030051261 Nucleotide sequences coding polynucleotide for use as tool in controlling eukaryotic translation
03/13/2003US20030051259 Packaging cells
03/13/2003US20030051258 Detecting agent for use in reducing or preventing ultraviolet radiation damage; obtain transgenic rodent, expose to ultraviolet radiation, administer modulating agent, monitor rodent cell for reduced cellular damage
03/13/2003US20030051257 Transgenic goat producing milk containing human granulocyte-colony stimulating factor
03/13/2003US20030050469 Induction of a Th1-like response in vitro
03/13/2003US20030050466 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer or autoimmune diaseses
03/13/2003US20030050463 Nucleotide sequences encoding fusion protein for use in generation of vaccines against viral diseases
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050459 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
03/13/2003US20030050458 Composition for use in the separation of preferential biopolymers from sample
03/13/2003US20030050457 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/13/2003US20030050456 Nucleotide sequences coding polypeptide for use in the treatment of brain and psychological disorders
03/13/2003US20030050454 Oligonucleotide sfor use in the treatment of cancer and viral diseases
03/13/2003US20030050451 Peptide for use in the diagnosis and treatment of tumors
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030050442 62 human secreted proteins
03/13/2003US20030050440 Gene regulating aureobasidin sensitivity
03/13/2003US20030050439 Polypeptide for use in the treatment of tumors and warts
03/13/2003US20030050273 Administering recombinant adeno-associated virus virions with a polynucleotide encoding a glial cell line-derived neutrotrophic factor polypeptide operably linked to expression control
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides